|
Apr 23
2011
|
Researchers at the Department of Neurosurgery at the University of Southern California found that hypericin—a compound found in St. John’s Wort—not only reduced tumor size in people suffering from cancerous brain or spinal tumors, it also increased the rate of survival from this tragic disease.
Approximately 10,000 Americans are diagnosed with a malignant glioma every year and the survival rate one year after diagnosis is only 50 percent. Heretofore, treatment involves a combination of surgery, chemotherapy, and radiation. Hypericin showed superior results as a treatment for this serious condition. Additionally, the St. John’s Wort compound was well-tolerated by the cancer patients, something that cannot be said for chemotherapy and radiation.


